Concepedia

Publication | Closed Access

A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma

DOI

57

Citations

18

References

2020

Year

David A. Reardon, Annick Desjardins, Olivier Rixe, Timothy F. Cloughesy, Shilpa Alekar, Jason H. Williams, Ray Li, Carrie Turich Taylor, Andrew B. Lassman
Investigational New Drugs

References

YearCitations

Page 1